Kai-Christian Sonntag, MD, PhD
Director, Laboratory for Translational Research on Neurodegeneration, Program for Neuropsychiatric Research
- Assistant Professor of Psychiatry
As a graduate of University of Heidelberg Medical School, Dr. Sonntag studied the molecular biology of viruses, and as a research fellow at the Transplantation Biology Research Center at Massachusetts General Hospital, he conducted research in transplantation immunology. In 2000, he joined McLean Hospital where his laboratory is integrated in the Program for Neuropsychiatric Research, directed by Dr. Bruce Cohen.
Amongst others, Dr. Sonntag’s work has contributed to developing a cell therapy for Parkinson’s disease (PD), and to understanding a role of dysregulated gene and miRNA expression networks in PD and schizophrenia, or dopaminergic and adrenergic receptors in hedonic and impulsive behavior. His research has also discovered a novel mechanism to regulate neurotrophic growth factor-associated signaling pathways by miRNAs in context of PD and Alzheimer’s disease (AD), and a role of dysfunctional bioenergetics in the pathogenesis of late-onset AD.
Dr. Sonntag’s scientific interest is to understand the molecular and cellular mechanisms and factors governing neuronal function and dysfunction in the aging brain and in neurodegenerative or neurological disorders.
His research is based on the concept that normal brain aging and the pathogeneses of sporadic neurological diseases are not a consequence of a few single or ‘disease-specific‘ factors alone, rather they are driven by holistic events that include one’s individual genetic and epigenetic condition, progression of aging, and lifestyle.
His work stems from the understanding that cell function depends on a strictly organized network orchestrating intracellular and environmental factors that include bioenergetics and metabolic processes, regulatory mechanisms of gene expression levels, and the effects of specific factors and signaling pathways that combined provide a molecular framework to achieve normal cell function. In contrast, progressive dysfunction and deregulation of these multiple interacting cellular components cause malfunction and ultimately lead to disease development.
Dr. Sonntag studies this concept on the molecular and cellular level using a translational research approach that integrates the analysis of human material, such as postmortem brains, primary cell systems, and neural cell populations generated from patients’- or healthy individuals’-derived induced pluripotent stem cells (iPSC), or induced neurons (iNs), in combination with molecular, biochemistry, and lentivirus-mediated gene-engineering technologies.
The Laboratory for Translational Research on Neurodegeneration is an integral part of the Program for Neuropsychiatric Research under the direction of Bruce M. Cohen, MD, PhD.
As part of the lab’s mission, Dr. Sonntag and his staff investigate the role of bioenergetics and metabolism in aging and in the pathogenesis of late-onset Alzheimer’s disease (LOAD), and recent work has supported the concept that dysfunctional bioenergetics may be a key mechanism contributing to the risk and pathophysiology of this neurodegenerative disorder.
The overall goal of this research is to provide new insight into the function and dysfunction of human neural cell populations in aging and neurological disorders, such as LOAD, and to identify mechanisms and molecules that can be translated to developing and testing novel diagnostic tools and therapeutics.
- Ryan A. Healy, Research Assistant
- Mariana Bormann, Senior Research Assistant
- Bruce M. Cohen, MD, PhD, McLean Hospital
- Nadja Freund, PhD, Ruhr University, Germany
- Kwang-Soo Kim, PhD, McLean Hospital
- Anna M. Krichevsky, PhD, Brigham and Women’s Hospital
- Donna L. McPhie, PhD, McLean Hospital
- Hyemyung Seo, Hanyang University, Ansan, South Korea
- T. Wilson Woo, MD, PhD, Beth Israel Deaconess Medical Center
Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens R, Benes F, Sonntag K-C. Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson disease pathology. Brain. 2009;132(Pt 7):1795-809. Epub 2008 Dec 3.
Kim W, Noh H, Lee Y, Jeon J, Shanmugavadivu A, McPhie DL, Kim K-W, Cohen BM, Seo H, Sonntag K-C. miR-126 regulates growth factor activities and vulnerability to toxic insult in neurons. Molecular Neurobiology. 2016;53(1):95-108. Epub 2014 Nov 19.
Sonntag K-C, Ryu W-I, Healy RA, Siegel AJ, McPhie DL, Forester B, Cohen BM. Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles. Scientific Reports 2017;7(1):14038.
Education & Training
- 1993 MD, University of Heidelberg, Heidelberg, Germany
- 1994 PhD in Virology, University of Heidelberg, Heidelberg, Germany
- 1993-1994 Internship in Internal Medicine, University of Heidelberg, Heidelberg, Germany
1994-1995 Residency in Virology, Institute for Medical Virology, University of Heidelberg, Heidelberg, Germany
- 1995-2000 Post-Doctoral Fellowship in Immunology, Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital
- 2000-2005 Post-Doctoral Fellowship in Neurobiology, McLean Hospital